共查询到20条相似文献，搜索用时 171 毫秒
1.
以不同剂量（１０^3.3-10^5.5TOCID50)IB肾型弱毒Ｊ９株、经眼、鼻途径接种１－６７日龄不同品种的鸡、接种后２周内无任何临床不良反应，表明了Ｊ９株的临床安全性，将Ｊ９株用ＳＰＦ雏鸡在负压隔离器内连续７次传代，无 无临床不良反应，并回收到病毒株，该毒株的临床安全性和遗传稳定性得到进一步证明。 相似文献
2.
参照NDV评价毒力的方法对1998—2008年间收集的25株H9N2AIV的致病性进行了比较研究。结果显示,25株H9N2AIV不同毒株间致病性有较大差异,大致分为3类：致病性偏强、致病性中等和致病性较弱。从中选出致病力有差异的8个毒株进行了1日龄雏鸡脑内接种指数（ICPI）、6周龄鸡静脉接种指数（IVPI）以及8周龄SPF鸡人工感染排毒试验,结果证明大部分毒株ICPI和IVPI基本上为0,排毒散毒的高峰期在攻毒后第5天到第6天。在25个毒株中,3#和12#表现出了比较高的致病性,不仅其EID50值最高（分别为10-8.8/0.2mL和10-8.8/0.2mL）、ELD50值最高（分别为10-7.9/0.2mL和10-8.7/0.2mL）,而且鸡胚平均死亡时间也最短（分别为66.5,69h）。3#、12#还出现了1日龄雏鸡脑内接种指数（分别为0.238,0.437）和6周鸡静脉内接种指数（分别为0.34,0.51）。在8周龄SPF鸡人工感染排毒试验中3#和12#毒株的排毒量大,排毒时间也明显长于其他毒株（第2～9天）。以上试验结果表明我国H9N2AIV不同毒株致病性有明显差异,呈多态性,致病性偏强的毒株造成鸡群较高的死亡率。 相似文献
3.
为探讨悬浮细胞制备的鸡新城疫-H9亚型禽流感二联灭活疫苗(La Sota株+BX13株)(以下简称二联灭活疫苗)的安全性和免疫产生期，试验用新城疫病毒(NDV)La Sota株和H9亚型禽流感病毒(AIV)BX13株分别接种BHK-21和MDCK悬浮细胞，收获抗原液，制备二联灭活疫苗；采用1 mL/只的剂量接种21日龄SPF鸡进行二联灭活疫苗的安全性试验；以0.02、0.05、0.1、0.3、0.5 mL/只的剂量接种21日龄SPF鸡，免疫后7、14、21 d采血测定NDV HI和AIVHI抗体，并于免疫后21日龄攻毒进行免疫保护试验和免疫产生期试验。结果显示：二联灭活疫苗对SPF鸡安全，鸡只无不良反应，疫苗吸收良好；各剂量组免疫后抗体水平均逐渐升高，免疫后21 d NDV HI效价为6.1～8.5 log2,AIV HI效价为7.5～11.2 log2；免疫后21 d,0.02 mL/只剂量组对两种毒株的攻毒保护率均为9/10，其余剂量组均为10/10保护。研究表明，二联灭活疫苗对SPF鸡安全，以0.1 mL/只的剂量免疫SPF鸡21 d可... 相似文献
4.
猪伪狂犬病病毒双基因缺失突变株(HB-98株)安全性、稳定性和免疫原性测定 总被引：1，自引：2，他引：1
对以伪狂犬病病毒鄂A株为亲本毒株构建的TK和gG双基因缺失突变株（PrV HB-98株）的增殖能力、安全性、毒力稳定性和免疫原性进行了测定。结果表明，PrV HB-98株在BHK-21细胞上的增殖滴度为10^7.0 TCID50／0．1mL以上，与亲本毒株相当，但高于Bartha株；与PrV鄂A株相比，病毒量为10^7.0TCID50的PrV HB-98株不引起BALB／c小鼠的死亡，毒力也低于Bartha株；将PrV HB-98株在PK-15细胞连续培养25代和在猪体内上连续继代5次，各代次突变株TK基因和LacZ基因能被稳定扩增，未出现毒力回复现象．表明该毒株具有良好的遗传稳定性；以10^5.0、10^6.0、10^7.0TCID50等3个不同剂量的PrV HB-98株接种于妊娠50～60d母猪和1日龄仔猪，母猪均能正常产仔．仔猪也未出现任何临床症状，证明该毒株有较好的安全性。另外，以10^5.0TCID50的PrV HB-98株接种于妊娠50～60d母猪和1日龄仔猪，分别于接种后28d和20d，用10^7.0TCID50 PrV鄂A强毒进行攻击．结果免疫猪都能抵抗强毒的攻击．获得保护，表明该毒株具有很强的免疫原性。综合上述结果表明，PrV HB-98株可以作为候选毒株．用于伪狂犬病基因工程疫苗的研制。 相似文献
5.
《黑龙江畜牧兽医》2015,(17)
为了筛选出安全性和免疫原性较好的理想免疫毒株,试验对6种传染性法氏囊病(infectious bursal disease,IBD)活疫苗中等毒力毒株(IBDV-CE、IBDV-M65、IBDV-V877、IBDV-NF8、IBDV-L、IBDV-B87)的生物学特性进行了比较。将传染性法氏囊病病毒(Infectious bursal disease virus,IBDV)的6个毒种分离繁殖后,分别接种SPF鸡胚测定其对鸡胚的毒力和鸡胚半数致死量(ELD50),再分别接种雏鸡测定毒株的安全性、对鸡新城疫病毒的免疫抑制性和免疫原性。结果表明:接种IBDV-CE株、IBDV-M65株的雏鸡法氏囊出现萎缩,接种IBDV-NF8株的雏鸡法氏囊稍萎缩,接种IBDV-L株的雏鸡出现肾脏出血,接种IBDV-B87株和IBDV-V877株的雏鸡法氏囊及肌肉组织无异常变化;6种毒株对鸡新城疫的免疫效果无影响。 相似文献
6.
蓝舌病病毒内蒙古株是继云南株、四川株之后,从隐性感染的山羊血液中分离获得的目前在中国唯一一株接近于蓝舌病毒血清17型的毒株.将他与云南毒株和美国17型毒株进行比较,发现其血清学反应群特异性完全相同;中和试验表明与云南毒株之间无交叉保护反应,与美国17型毒株有交叉保护反应,但中和不彻底;电镜下其形态与云南、美国毒株完全一致;核酸电泳分析,具有4组10基因片段,带型为3:3:3:1,第7、8、9片段不融合,与云南、美国毒株基本一致,但1、2、3组中迁移率有差异;人工接种绵羊、山羊、鸡胚,其病理变化和临床反应与云南、美国毒株比较有较大差异. 相似文献
7.
刘伯淳 《上海畜牧兽医通讯》1991,(3)
本文报道日本1986～1987年自然暴发肾病-肾炎综合症的鸡肾脏分离7株传染性支气管炎病毒(IBV),通过眼、鼻接种于1日龄无特异病原(SPF)鸡,或经静脉接种于4～5周龄鸡,检查其肾脏致病力。有6株在接种10天内引起肾脏病变,与野外病例类似,但各毒株的肾脏病变发生率差异较大。用交叉中和作用测 相似文献
8.
为研究H9N2亚型禽流感病毒(AIV)的变异情况,采用交叉HI试验、细胞中和试验和攻毒保护试验对1998-2008年间分离到的25株H9N2 AIV的抗原性和免疫原性进行了研究.结果显示,依据不同毒株与Hp株免疫产生HI抗体的结果可将25个毒株分为3类,第1类HI效价4.0log2～5.0log2的为12#、17#、18#;第2类毒株HI效价6.0log2～7.0log2的为2#、21#、5#、22#、11#、25#、15#、16#;其余毒株的HI效价为7.0log2～8.0log2.这证实不同H9N2 AIV流行毒株间的抗原性有差异.选取代表性的8株H9N2 AIV毒株进行中和试验,结果显示其抗原相关性在0.42～0.84.除了3#与14#、11#与17#的抗原性有明显差异外(相关性R值分别为0.46、0.42),其余毒株间的抗原性无明显差异或仅有较小的差异.抗原性不同的H9N2 AIV株对Hp株免疫鸡的攻毒保护试验显示Hp株能够对抗原性有差异的攻毒株(10#、12#、17#)产生有效保护(9/10),联合攻毒试验结果显示Hp毒株免疫鸡可抗其他毒株(9#+15#和16#+17#)的联合攻击,保护率9/10以上.以上结果显示,H9N2 AIV Hp株与多数流行毒株间在免疫原性上无明显差异,H9N2 AIV多数流行毒株间的免疫原性没有发生根本改变. 相似文献
9.
多年来我们对中国马传贫病理解剖学、免疫形态学进行了大量研究,但所用的强毒株均为国内分离株。应用国外马传贫强毒感染中国马尚属空白。为了探讨国外毒株与国内毒株在引起病理变化上的异同,开展了此项工作。材料和方法一,试验马:共27匹,年龄4～6岁,人工接种Wyoming株(剂量为原液～10~(-5))20匹,接种中国辽毒株(10~(-6))7匹,根据其临床表现,按中国传贫马、驴病理分型标 相似文献
10.
经鸡胚绒毛尿囊膜(CAM)接种、易感鸡接种试验、电镜观察,从安徽地区疑似病鸡的法氏囊组织分离到3株传染性法氏囊病毒。分离株人工感染4周龄鸡,致死率分别为92%、83%、67%。接种9～10SPF鸡胚测得的鸡胚半数致死量(ELD50)分别为10-6.8/0.2mL、10-5.4/0.2mL、10-4.6/0.2mL。应用Nested-PCR分别对3株分离株VP2基因高变区进行克隆测序和序列分析,结果表明:3个分离株与国内外参考超强毒株的核苷酸同源性为97.2%～99.5%,氨基酸同源性为99.3%～100%,VP2高变区核苷酸和推导的氨基酸符合传染性法氏囊病病毒超强毒株特征。 相似文献
11.
J M Sharma 《Avian diseases》1981,25(4):882-893
Chickens of 2 genetic lines (lines P and N) were inoculated with a pathogenic strain of Marek's disease (MD) virus (MDV) and chronologically examined for disease response and natural killer (NK) cell expression. The NK cell reactivity was assayed in an in vitro cytotoxicity assay in which effector cells from the spleen of test chickens were reacted with 51Cr-labeled LSCC-RP9 target cells. Chickens of line P developed progressive debilitating disease and a high incidence of gross tumors and death. The NK cell reactivity of line-P chickens infected with MDV was significantly lower than that of uninfected control hatchmates. In contrast, NK cell levels were significantly elevated in MDV-inoculated line-N chickens that were resistant to MD and in chickens of lines P or N that had been inoculated with herpesvirus of turkeys (HVT). NK cell levels were also elevated in line P if chickens were vaccinated with HVT before infection with MDV. Inhibition of NK reactivity in susceptible chickens and elevation of reactivity in naturally resistant or vaccinated chickens may indicate a role for the NK cell system in regulating resistance to MD. 相似文献
12.
We evaluated a recently developed live vaccine candidate for fowl typhoid (FT)-JOL916, a lon/cpxR mutant of Salmonella Gallinarum (SG)-by comparing its safety and efficacy with that of the well-known rough mutant strain SG9R vaccine in 6-wk-old Hy-Line hens. Forty-five chickens were divided into three groups of 15 chickens each. The chickens were then intramuscularly inoculated with 2 x 10(7) colony-forming units (CFUs) of JOL916 (JOL916 group), 2 x 10(7) CFUs of SG9R (SG9R group), or phosphate-buffered saline (control group). After vaccination, no clinical symptoms were observed in any of the groups. No differences in body weight increase were detected among the three groups postvaccination. A cellular immune response was observed at 2 wk postvaccination (wpv) in the JOL916 group with the peripheral lymphocyte proliferation assay, whereas no response was detected in the SG9R group. Elevation of SG antigen-specific plasma immunoglobulin was observed 2 and 3 wpv in the JOL916 and SG9R vaccine groups, respectively. After virulent challenge on day 25 postvaccination, 0, 1, and 15 chickens in the JOL916 group, SG9R group, and control group, respectively, died by 12 days postchallenge; the death rate of the SG9R vaccine group was statistically similar to that of the JOL916 group. Postmortem examination revealed that the JOL916 vaccine offered more efficient protection than the SG9R vaccine, with significantly decreased hepatic necrotic foci scores, splenic enlargement scores, necrotic foci scores, and recovery of the challenge strain from the spleen. Vaccination with JOL916 appears to be safe and offers better protection than SG9R against FT in chickens. 相似文献
13.
应用电镜技术、血清学检查、生物学试验等方法,从未注射过疫苗的某自然发病鸡群分离出一株新城疫病毒。该分离株对１０日龄鸡胚的平均致死时间为１１６小时,静脉接种致病指数为０．０６,其毒力介于新城疫病毒的ＬａＳｏｔａ株与Ｖ４株之间。免疫原性试验结果表明,该分离株具有免疫后无不良反应、免疫后６天开始产生抗体、产生的抗体效价高、对新城疫强毒的攻击能１００％保护等特点,是一株良好的新城疫候选疫苗株 相似文献
14.
《Veterinary microbiology》2014,168(1):88-97
To compare the pathogenicity of PPMV-1 in pigeons and chickens, both species of birds were experimentally infected with strain pi/CH/LHLJ/110822, which was isolated from a pigeon in China. The clinical signs, gross lesions, and histopathological changes were observed in pigeons inoculated with pi/CH/LHLJ/110822. The morbidity and mortality rates were 80% and 70% in pigeons, respectively, whereas there were no clinical signs or gross lesions in chickens inoculated with the same strain. The viral loads in tissue samples were detected by real-time RT-PCR, indicating that six tissue samples (i.e., kidney, lung, brain, trachea, Harderian glands, and proventriculus) had detectable viral RNA in all dead pigeons, and significant differences in viral loads between pigeons and chickens were observed in several tissue samples (i.e., Harderian glands, proventriculus, duodenum, pancreas, small intestine, and large intestine) on 3 days post-inoculation (dpi) and in brain tissue on 7 dpi. In general, viral loads in pigeons were higher than those in chickens, whereas antibody titers in pigeons were lower than those in chickens. These results showed differences in pathogenicity, efficiency of viral RNA replication, and humoral immunity, indicating different susceptibilities between the host species. Additionally, the cross hemagglutination inhibition assay and cross virus neutralization tests demonstrated that pi/CH/LHLJ/110822 antigenicity was different from those of strains La Sota and F48E9. 相似文献
15.
为探索禽脑脊髓炎病毒强毒VR株对SPF鸡的致病性,开展了不同接种途径和不同日龄SPF鸡的致病力试验。不同接种途径致病力试验结果表明,AEV VR株口服后不能引起发病;刺种、肌肉注射途径接种随着日龄增大,发病率降低;脑内注射途径接种可引起试验鸡全部发病。最小致病量试验结果显示,VR株脑内注射攻毒的最小致病量为10~(2.0) EID_(50)。不同日龄SPF鸡的致病力试验结果表明,随着试验鸡日龄的增大,其致病力略有差异,日龄越小,发病率越高。结果表明,AEV VR株脑内攻毒70日龄内SPF鸡的发病率为80%及以上,攻毒剂量为10~(4.0)EID_(50)。 相似文献
16.
试验旨在探讨不同来源的传染性支气管炎病毒(Infectious bronchitis virus,IBV)诱导SPF鸡发病的免疫机制。选用140只1日龄SPF白来航鸡,随机分为4组,3组攻毒组通过滴鼻点眼途径分别接种鸡源IBV强毒株、鸡源IBV弱毒株和野鸡源IBV毒株3个毒株,对照组以同种方式接种等量灭菌的磷酸盐缓冲液。在感染后12 h、36 h、72 h、7 d和14 d,每组随机选取5只进行剖检,并分别采集法氏囊、肾脏和气管组织,剩余鸡用于观察临床症状、发病及死亡情况。应用实时荧光定量PCR检测攻毒后不同时间点采集的各组织中IBV的病毒载量、Toll样受体(Toll-like receptors,TLRs)及部分细胞因子(白细胞介素(interleukin,IL)和干扰素(interferon,IFN))表达量的变化。结果显示,感染不同来源IBV毒株之后仅鸡源IBV强毒株感染组SPF鸡出现抑郁、翅膀下垂、甩头等典型的临床症状,且在感染后5~10 d共有7只死亡,死亡率为20%。病理剖检发现,感染鸡源IBV强毒株的鸡肾脏肿大、尿酸盐沉积和有花斑样病变,而感染野鸡源IBV毒株、鸡源IBV弱毒株和对照组的鸡无明显的眼观病变。实时荧光定量PCR结果显示,在鸡源IBV强毒株组的法氏囊、肾脏和气管3个组织中均检测到病毒。对照组和野鸡源IBV毒株组中均未检测到病毒,鸡源IBV弱毒株组只在部分组织中检测到病毒。在感染后72 h,鸡源IBV强毒株组与其他各组相比,TLR1、TLR2、TLR3、TLR5、TLR7和TLR15基因在法氏囊中的表达量均显著升高(P<0.05),IL-6和IFN-β参与更强烈的抗病毒免疫反应;在感染后7 d,鸡源IBV弱毒株组与其他各组相比,肾脏中TLR2、TLR3、TLR15、TLR21、IL-6和IL-18基因表达量均显著升高(P<0.05)。野鸡源IBV感染后36 h法氏囊组织中IFN-γ基因表达量显著上调(P<0.05)。综上所述,3个IBV毒株中仅鸡源IBV强毒感染引起SPF鸡典型临床发病症状与可视组织病变,且可提高SPF鸡组织中免疫相关因子的基因表达量。本研究结果揭示,不同来源的IBV对SPF鸡的不同致病性与其感染诱导的免疫反应不同有关。 相似文献
17.
Santin ER Shamblin CE Prigge JT Arumugaswami V Dienglewicz RL Parcells MS 《Avian diseases》2006,50(1):96-103
We recently reported a comparison of glycoprotein-encoding genes of different Marek's disease virus pathotypes (MDVs). One mutation found predominantly in very virulent (vv)+MDVs was a 12-bp (four-amino acid) deletion in the glycoprotein L (gL)-encoding gene in four of 23 MDV strains examined (three were vv+MDVs and one was a vvMDV). This mutation was noted in the gL of the TK (615K) strain, but not in the RL (615J) strain of MDV. These strains have identical mutations in the meq gene characteristic of vv+MDVs but can be distinguished by the mutation in the gL-encoding gene. The TK strain was originally isolated from vaccinated chickens and appeared to confer or enhance horizontal transmission of the vaccine virus, herpesvirus of turkeys (HVT). Because the molecular basis for increased virulence of MDV field strains is unknown, we hypothesized that one mechanism might be by coreplication of MDV-1 strains with HVT and that it could be mediated by the mutation of gL, an essential component of the glycoprotein H/L complex. In this study, we compared the pathogenicity of TK (615K) and RL (615J) strains of MDV in the presence and absence of simultaneous HVT coinfection. MDV infections were monitored at the levels of viremia (for both MDV-1 and HVT), clinical signs of MD, tumor incidence, and mortality in 1) inoculated chickens, 2) chickens exposed at 1 day of age, 3) chickens exposed at 2 wk of age, and 4) chickens exposed to both TK/HVT- and RL/HVT-infected chickens at 6 wk of age. We found high incidences of clinical MD signs in all inoculated treatment groups and all chickens exposed to TK and RL viruses, regardless of the presence of HVT. The median time to death of chickens exposed to TK1HVT-infected chickens, however, was lower than the other treatment groups for contact-exposed chickens. Although this difference was not considered to be statistically significant to a rigorously interpreted degree because of the removal of chickens for sampling from the test groups, these data suggest that replication of the TK strain and HVT, when coadministered, might incrementally affect the virulence of MDV-1 strains. The strict correlation of this enhancement of virulence with the mutation in gL, however, requires additional experiments with genetically identical MDV background strains. 相似文献
18.
The clinical response of 7-day-old chickens to Newcastle disease vaccine strains V4, B1 and La Sota administered by the aerosol method was used to study the residual virulence of the strains. Parameters used to assess the severity of the clinical response were the number of sneezes recorded and the weight gain of chickens in the 10 day test period. The demeanour of the chickens was also observed.
Strain V4 was less pathogenic for chickens than strain B1 which was less virulent than strain La Sota. Statistically significent differences were recorded in weight gain and the number of sneezes detected in each group. An unexpected mild respiratory disease recorded in chickens dosed with strain V4 may have been associated with administration of virus as a fine particle aerosol. Aust. vet. J. 61: 47–49 相似文献
Strain V4 was less pathogenic for chickens than strain B1 which was less virulent than strain La Sota. Statistically significent differences were recorded in weight gain and the number of sneezes detected in each group. An unexpected mild respiratory disease recorded in chickens dosed with strain V4 may have been associated with administration of virus as a fine particle aerosol. Aust. vet. J. 61: 47–49 相似文献
19.
表现腺胃炎的蛋用型鸡J亚群-白血病病毒的分离与鉴定 总被引：2，自引：1，他引：1
从表现腺胃炎的尼克珊瑚粉商品代蛋鸡中分离到J亚群-白血病病毒(ALV-J)。将病料或鸡白细胞接种于CEF,培养12 d,分别采用单克隆抗体间接免疫荧光试验检测,结果10只鸡中有9只鸡分离到ALV-J,其中有4只鸡还存在与禽网状内皮增生病病毒(REV)的共感染。通过PCR扩增gp85基因,与已发表的20株ALV-J进行同源性比较。结果表明,与来自白羽肉鸡的HPRS103的同源性为97.8%,而与来自蛋用型鸡的SD07LK1株的同源性为93.0%。本研究发现,在某些仅仅发生腺胃炎的鸡也可能普遍存在ALV-J感染,再次显示了腺胃炎病料中病毒感染的多样性。ALV-J可能成为致腺胃炎的病原之一,但其致病作用有待进一步研究。 相似文献
20.
传染性喉气管炎新城疫鸡痘重组病毒免疫效力的研究 总被引：1，自引：2，他引：1
在表达鸡传染性喉气管炎病毒(ILTV)糖蛋白gB基因和新城疫病毒(NDV)F基因的重组鸡痘病毒(rF-PV-gB-F)安全性检验合格后,以5.0×101~5.0×104PFU不同含量按0.1mL/鸡的剂量免疫100只30日龄SPF鸡,30d后分组分别用ILTVWG株和NDVF48E9株强毒进行攻击。免疫鸡抗鸡痘病毒抗体都转为阳性,痘反应和接种剂量有关,重组疫苗的最小反应剂量为50PFU。重组疫苗可以诱发对新城疫和传染性喉气管炎的保护,0.1mL/鸡的接种量在500~5000PFU浓度范围内的免疫效果最好,对于ILTV攻击的发病保护率在70%以上,对NDV强毒攻击的抗死亡保护率可以达到80%,这为进一步考察疫苗的免疫效力试验以及进行田间试验奠定了基础。 相似文献